semaglutide vision blurry Could drugs for diabetes, obesity affect eyesight? Possible link between diabetes medications

The primary outcome of this study was the first diagnosis of CRC within 15 years from the initial treatment of GLP-1RAs or non-GLP-1RA diabetes medications (insulin, metformin, alpha-glucosidase inhibitors, dipeptidyl-peptidase-4 inhibitors (DPP-4i), sodium-glucose cotransporter-2 inhibitors (SGLT2i), sulfonylureas (SU), and thiazolidinediones (TZD))

After 4 weeks, increase to 1mL (10 mg daily which is the final recommended dose

It mimics the GLP-1 hormone, increasing satiety, slowing digestion, and reducing calorie intake

Sold for in-vitro laboratory research only

Effect on cell surface hydrophobicity and susceptibility of Helicobacter pylori to medicinal plant extracts

Especially for Wegovy, which, in 2021, was approved by the FDA for obesity and weight-related conditions like high blood pressure